Japan · Delayed Price · Currency is JPY Nipro Company Description
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide.
The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filters, hemoconcentrators, and venous and arterial cannulae; and enzymes, as well as contract development and manufacturing services.
In addition, the company offers pharmaceutical combination products consisting of dual chamber bags, pre-filled syringes, and half-type kits; and integrated services, such as development, manufacturing, inspection, and packaging.
Further, it provides glass containers, rubber stoppers, glass tubes, and other supplies for medical use; supplies for other industries; and drug administration systems, as well as autologous bone-marrow mesenchymal stem cells, culture products, and cell preservation products.
The company was founded in 1947 and is headquartered in Settsu, Japan.
| Country | Japan |
| Founded | 1947 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 38,593 |
| CEO | Tsuyoshi Yamazaki |
Contact Details
Address: 3-26, Senriokashinmachi Settsu, 566-8510 Japan | |
| Phone | 81 6 6310 6804 |
| Website | nipro.co.jp |
Stock Details
| Ticker Symbol | 8086 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3673600007 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Tsuyoshi Yamazaki | Chief Executive Officer |
| Takehito Yogo | Chief Financial Officer |